SHANGHAI ALLIST PHARMACEUTICALS COSS

SHANGHAI ALLIST PHARMACEUTICALS CO

85.63CNYD
+1.42+1.69%
在3月28日 08:50 [GMT]結束
CNY
沒有交易
在超級圖表上查看

688578基本面

SHANGHAI ALLIST PHARMACEUTICALS CO收入明細概覽

中國對收入數字的貢獻最大 — 去年它帶來了 SHANGHAI ALLIST PHARMACEUTICALS CO1.98 B CNY, 以及前一年 — 790.94 M CNY.

按來源
2017
2018
2019
2020
2021
2022
2023
‪0.00‬
‪‪550.00 M‬‬
‪‪1.10 B‬‬
‪‪1.65 B‬‬
‪‪2.20 B‬‬
Anti-tumor
Technical Licensing
Other Business
Lansoprazole Enteric Capsules
Other
貨幣:CNY
2017
2018
2019
2020
2021
2022
2023
Anti-tumor
‪‪235.71 M‬‬
‪‪790.32 M‬‬
‪‪1.98 B‬‬
Technical Licensing
‪‪294.37 M‬‬
‪‪620.70 K‬‬
‪‪40.61 M‬‬
Other Business
‪‪16.75 K‬‬
‪‪58.26 K‬‬
‪‪63.91 K‬‬
Lansoprazole Enteric Capsules
‪‪629.70 K‬‬
‪‪545.45 K‬‬
Other
‪‪15.43 K‬‬
按國家
2017
2018
2019
2020
2021
2022
2023
‪0.00‬
‪‪550.00 M‬‬
‪‪1.10 B‬‬
‪‪1.65 B‬‬
‪‪2.20 B‬‬
China
Overseas
貨幣:CNY
2017
2018
2019
2020
2021
2022
2023
China
‪‪629.72 K‬‬
‪‪560.89 K‬‬
‪‪236.57 M‬‬
‪‪790.94 M‬‬
‪‪1.98 B‬‬
Overseas
‪‪293.50 M‬‬
‪‪35.41 M‬‬